Moderna Inc

MRNANASDAQ

$226.13

-5.22-2.26%

Dern. MÀJ: Nov 13, 12:29 PM

Aperçu Actualités Graphiques Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

PRO

Pourquoi cela bouge-t-il ?:Moderna shares are trading lower. Investors may be taking profit after the ...

Résultats: Les résultats Q3 2026 ont été publiés le ven. nov. 6th, avant l'ouverture du marché

Conférence téléphonique: La conférence téléphonique la plus récente a commencé à 8:00 AM, il y a 7 jours

Cliquez pour voir la webdiffusion

PRO

Pourquoi cela bouge-t-il ?:Moderna shares are trading lower. Investors may be taking profit after the ...

Résultats: Les résultats Q3 2026 ont été publiés le ven. nov. 6th, avant l'ouverture du marché

Conférence téléphonique: La conférence téléphonique la plus récente a commencé à 8:00 AM, il y a 7 jours

Cliquez pour voir la webdiffusion

Moderna (MRNA) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Moderna (MRNA) stock.

Analyst Consensus — 20 Analysts

6Buy

11Hold

3Sell

# Analysts20

Latest Upgrades and Downgrades for Moderna Stock

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$137→$195
—	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$230→$305
—	William Blair	Myles Minter	Downgrade	Outperform→Market Perform	—
—	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$167→$230
—	TD Cowen	Tyler Van Buren	PT Raise	Hold	$40→$90
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$120→$137
—	Morgan Stanley	Terence Flynn	PT Raise	Equal-Weight	$89→$95
—	Citigroup	Geoff Meacham	Downgrade	Neutral→Sell	$60→$80
—	Rothschild & Co	Simon Baker	Downgrade	Neutral→Sell	$40→$81
—	Argus Research	John Eade	Upgrade	Hold→Buy	$180
—	Wolfe Research	Alexandria Hammond	Upgrade	Underperform→Peer Perform	—
—	Barclays	Eliana Merle	PT Raise	Equal-Weight	$48→$125
—	JP Morgan	Jessica Fye	PT Raise	Underweight	$40→$77
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$67→$120
—	UBS	Michael Yee	PT Raise	Neutral	$50→$150
—	Morgan Stanley	Terence Flynn	PT Raise	Equal-Weight	$39→$89
—	William Blair	Myles Minter	Upgrade	Market Perform→Outperform	—
—	Citigroup	Geoff Meacham	PT Raise	Neutral	$41→$60
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$49→$67
—	Morgan Stanley	Matthew Harrison	PT Raise	Equal-Weight	$33→$39

Moderna Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Moderna (MRNA) Stock Price Target 2026

Latest Upgrades and Downgrades for Moderna Stock

Moderna (MRNA) Stock Price Target 2026

Latest Upgrades and Downgrades for Moderna Stock

Analyst Ratings News

PRO
Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $195

PRO
Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Merck One of Top Large-Cap Biopharma Picks-Analyst

This M&T Bank Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

PRO
William Blair Downgrades Moderna to Market Perform

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $195

PRO
Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Merck One of Top Large-Cap Biopharma Picks-Analyst

This M&T Bank Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

PRO
William Blair Downgrades Moderna to Market Perform

Moderna Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Moderna (MRNA) Stock Price Target 2026

Latest Upgrades and Downgrades for Moderna Stock

Moderna (MRNA) Stock Price Target 2026

Latest Upgrades and Downgrades for Moderna Stock

Analyst Ratings News

PROGoldman Sachs Maintains Neutral on Moderna, Raises Price Target to $195

PROPiper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Merck One of Top Large-Cap Biopharma Picks-Analyst

This M&T Bank Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

PROWilliam Blair Downgrades Moderna to Market Perform

People Also Watch

People Also Watch

Analyst Ratings News

PROGoldman Sachs Maintains Neutral on Moderna, Raises Price Target to $195

PROPiper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Merck One of Top Large-Cap Biopharma Picks-Analyst

This M&T Bank Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

PROWilliam Blair Downgrades Moderna to Market Perform

PRO
Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $195

PRO
Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

PRO
William Blair Downgrades Moderna to Market Perform

PRO
Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $195

PRO
Piper Sandler Reiterates Overweight on Moderna, Raises Price Target to $305

PRO
William Blair Downgrades Moderna to Market Perform